Ontogeny of methamphetamine-induced neurotoxicity and associated hyperthermic response

Developmental Brain Research

Volumn 103, Issue 2, 1997, Pages 155-162

  Cappon, Gregg D ^a   Morford, Laronda L ^a   Vorhees, Charles V ^a  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

Caudate putamen; Development; Dopamine; GFAP; Methamphetamine; Neurotoxicity; Serotonin

Indexed keywords

DOPAMINE; GLIAL FIBRILLARY ACIDIC PROTEIN; METHAMPHETAMINE; SEROTONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; CAUDATE NUCLEUS; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; HYPERTHERMIA; NEOSTRIATUM; NEUROTOXICITY; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; PUTAMEN; RAT; THERMOREGULATION;

EID: 0030725296     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-3806(97)81791-9     Document Type: Article

References (53)

1. Ali S.F., Holson R.R., Newport G.D., Slikker W., Bowyer J.F. Development of dopamine and N-methyl-D-aspartate systems in rat brain: the effect of prenatal phencyclidine exposure. Dev. Brain Res. 73:1993;25-33.
2. Ali S.F., Newport G.D., Holson R.R., Slikker W., Bowyer J.F. Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice. Brain Res. 658:1994;33-38.
3. Bowyer J.F., Davies D.L., Schmued L., Broening H.W., Newport G.D., Slikker W., Holson R.R. Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J. Pharmacol. Exp. Ther. 268(3):1994;1571-1580.
4. Bowyer J.F., Gough B., Slikker W., Lipe G.W., Newport G.D., Holson R.R. Effects of a cold environment or age on methamphetamine-induced dopamine release in the caudate putamen of female rats. Pharmacol. Biochem. Behav. 44:1993;87-98.
5. Cappon G.D., Broening H.W., Pu C., Morford L.L., Vorhees C.V. α-Phenyl-n-tert butyl nitrone (PBN) attenuates methamphetamine-induced depletion of striatal dopamine without altering hyperthermia. Synapse. 241:1996;73-81.
6. Chiueh C.C., Miyake H., Peng M. Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism. Adv. Neurol. 60:1993;251-258.
7. Clow D.W., Jhamandas K. Characterization of L-glutamate action on the release of endogenous dopamine from the rat caudate-putamen. J. Pharmacol. Exp. Ther. 248:1989;722-728.
8. Cubells J.F., Rayport S., Rajendran G., Sulzer D. Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J. Neurosci. 14:1994;2260-2271.
9. De Vito M.J., Wagner G.C. Methamphetamine-induced neuronal damage: a possible role for free radicals. Neuropharmacology. 28:1989;1145-1150.
10. De Vito M.J., Wagner G.C. Functional consequences following methamphetamine-induced neuronal damage. Psychopharmacology. 97:1989;432-435.
11. Del Maestro R., McDonald W. Distribution of superoxide dismutase, glutathione peroxidase and catalase in developing rat brain. Mech. Ageing Dev. 41:1987;29-38.
12. Dell'Anna M.E., Luthman J., Lindqvist E., Olson L. Development of monoamine systems after neonatal anoxia in rats. Brain Res. Bull. 32:1993;159-170.
13. Durkot M.J., Francesconi R.P., Hubbard R.W. Effect of age, weight, and metabolic rate on endurance, hyperthermia and heatstroke mortality in a small animal model. Aviat. Space Environ. Med. 57:1986;974-979.
14. Eisch A.J., Gaffney M., Weihmuller F.B., O'Dell S.J., Marshall J.F. Striatal subregions are differentially vulnerable to the neurotoxic effects of methamphetamine. Brain Res. 598:1992;321-326.
15. Eng L.F., Ghirnikar R.S. GFAP and astrogliosis. Brain Pathol. 4:1994;229-237.
16. Farfel G.M., Seiden L.S. Role of hypothermia in the mechanism of protection against serotonergic toxicity. II. Experiments with methamphetamine, p-chloroamphetamine, fenfluramine, dizocilpine and dextromethorphan. J. Pharmacol. Exp. Ther. 272:1995;868-875.
17. Floyd R.A., Carney J.M. Free radical damage to protein and DNA: mechanisms involved and relevant observations on brain undergoing oxidative stress. Ann. Neurol. 32:1992;S22-S27.
18. M. Fukumura, G.D. Cappon, H.W. Broening, C.V. Vorhees, Methamphetamine-induced dopamine and serotonin reductions in the neostriatum are not gender-specific in rats with comparable hyperthermic responses, Neurotoxicol. Teratol. (1997) in press.
19. Gazzara R.A., Fisher R.S., Howard S.G. The ontogeny of amphetamine-induced dopamine release in the caudate-putamen of the rat. Dev. Brain Res. 28:1986;213-220.
20. Giovanni A., Liang L.P., Hastings T.G., Zigmond M.J. Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine. J. Neurochem. 64:1995;1819-1825.
21. Giros B., Jaber M., Jones S., Wightman R.M., Caron M. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 379:1996;606-612.
22. Graham D.G., Tiffany S.M., Bell W.R., Gutknecht W.F. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol. Pharmacol. 14:1978;644-653.
23. Gupta A., Shukla G.S. Development of brain free radical scavenging system and lipid peroxidation under the influence of gestational and lactational cadmium exposure. Hum. Exp. Toxicol. 144:1995;28-33.
24. Hirata H., Ladenheim B., Rothman R.B., Epstein C., Cadet J.L. Methamphetamine-induced serotonin neurotoxicity is mediated by superoxide radicals. Brain Res. 677:1995;345-347.
25. Hotchkiss A.J., Gibb J.W. Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J. Pharmacol. Exp. Ther. 214:1980;257-262.
26. Hotchkiss A.J., Morgan M.E., Gibb J.W. The long-term effects of multiple doses of methamphetamine on neostriatal tryptophan hydroxylase, tyrosine hydroxylase, choline acetyltransferase and glutamate decarboxylase activities. Life Sci. 25:1979;1373-1378.
27. Hyde C.E., Bennett B.A. Similar properties of fetal and adult amine transporters in the rat brain. Brain Res. 646:1994;118-123.
28. 3H]-5-hydroxytryptamine uptake systems in rat brain regions. Br. J. Pharmacol. 67:1979;387-391.
29. 3H]dopamine from isolated corpus striatum by amphetamine, fenfluramine and unlabeled dopamine. Biochem. Pharmacol. 31:1982;983-992.
30. 2+-independent dopamine release from striatal slices: a possible role of reverse dopamine transport. J. Pharmacol. Exp. Ther. 256:1991;1132-1138.
31. Lucot J.B., Wagner G.C., Schuster C.R., Seiden L.S. Decreased sensitivity of rat pups to long-lasting dopamine and serotonin depletions produced by methylamphetamine. Brain Res. 247:1982;181-183.
32. Maruyama W., Takahashi T., Minami M., Takahashi A., Dostert P., Nagatsu T., Naoi M. Cytotoxicity of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines. Adv. Neurol. 60:1993;224-230.
33. Miller D.B., O'Callaghan J.P. Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse. J. Pharmacol. Exp. Ther. 270:1994;752-760.
34. O'Callaghan J.P. Quantification of glial fibrillary acidic protein: comparison of slot-immunobinding assays with a novel sandwich ELISA. Neurotoxicol. Teratol. 13:1991;275-281.
35. O'Callaghan J.P. Assessment of neurotoxicity: use of glial fibrillary acidic protein as a biomarker. Biomed. Environ. Sci. 4:1991;197-206.
36. O'Callaghan J.P. Biochemical analysis of glial fibrillary acidic protein as a quantitative approach to neurotoxicity assessment: advantages, disadvantages and application to the assessment of NMDA receptor antagonist induced neurotoxicity. Psychopharmacol. Bull. 30:1994;549-554.
37. O'Callaghan J.P., Miller D.B. Acute exposure of the neonatal rat to triethyltin results in persistent changes in neurotypic and gliotypic proteins. J. Pharmacol. Exp. Ther. 244:1988;368-378.
38. Pu C., Fisher J.E., Cappon G.D., Vorhees C.V. The effects of amfonelic acid, a dopamine uptake inhibitor, on methamphetamine-induced dopaminergic terminal degeneration and astrocytic response in rat striatum. Brain Res. 649:1994;217-224.
39. Pu C., Vorhees C.V. Developmental dissociation of methamphetamine-induced depletion of dopaminergic terminals and astrocyte reaction in rat striatum. Dev. Brain Res. 72:1993;325-328.
40. Pu C., Vorhees C.V. Protective effects of MK-801 on methamphetamine-induced depletion of dopaminergic and serotonergic terminals and striatal astrocytic response: an immunohistochemical study. Synapse. 19:1995;97-104.
41. Ricaurte G.A., Guillery R.W., Seiden L.S., Schuster C.R., Moore R.Y. Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res. 235:1982;93-103.
42. Shivakumar B.R., Anandatheerthavarada H.K., Ravindranath V. Free radical scavenging systems in developing rat brain. Int. J. Dev. Neurosci. 9:1991;181-185.
43. Slivka A., Cohen G. Hydroxyl radical attack on dopamine. J. Biol. Chem. 260:1985;15466-15472.
44. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olsen B.J., Klenk D.C. Measurement of protein using bicinchonic acid. Anal. Biochem. 150:1985;76-85.
45. Sonsalla P.K., Nicklas W.J., Heikkila R.E. Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science. 243:1989;398-400.
46. Sonsalla P.K., Riordan D.E., Heikkila R.E. Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice. J. Pharmacol. Exp. Ther. 256:1991;506-512.
47. Spiers D.E., Adair E.R. Ontogeny of homeothermy in the immature rat: metabolic and thermal responses. J. Appl. Physiol. 60:1986;1190-1197.
48. Stephans S.E., Yamamoto B.K. Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux. Synapse. 17:1994;203-209.
49. Sulzer D., Maidment N.T., Rayport S. Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. J. Neurochem. 60:1993;527-535.
50. Wagner G.C., Carelli R.M., Jarvis M.F. Pretreatment with ascorbic acid attenuates the neurotoxic effects of methamphetamine in rats. Res. Commun. Chem. Pathol. Pharmacol. 47:1985;221-228.
51. Wagner G.C., Ricaurte G.A., Seiden L.S., Schuster C.R., Miller R.J., Westley J. Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res. 181:1980;151-160.
52. Wagner G.C., Schuster C.R., Seiden L.S. Neurochemical consequences following administration of CNS stimulants to the neonatal rat. Pharmacol. Biochem. Behav. 14:1981;117-119.
53. Weir M.D., Patel A.J., Hunt A., Thomas D.G.T. Developmental changes in the amount of glial fibrillary acidic protein in three regions of the rat brain. Dev. Brain Res. 15:1984;147-154.